Rabies and Rabies-Related Lyssaviruses by Iowa State University Center for Food Security and Public Health
Center for Food Security and Public Health
Technical Factsheets Center for Food Security and Public Health
11-1-2012
Rabies and Rabies-Related Lyssaviruses
Iowa State University Center for Food Security and Public Health
Follow this and additional works at: http://lib.dr.iastate.edu/cfsph_factsheets
Part of the Animal Diseases Commons, and the Veterinary Infectious Diseases Commons
This Report is brought to you for free and open access by the Center for Food Security and Public Health at Iowa State University Digital Repository. It
has been accepted for inclusion in Center for Food Security and Public Health Technical Factsheets by an authorized administrator of Iowa State
University Digital Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Iowa State University Center for Food Security and Public Health, "Rabies and Rabies-Related Lyssaviruses" (2012). Center for Food
Security and Public Health Technical Factsheets. 106.
http://lib.dr.iastate.edu/cfsph_factsheets/106
 © 2004-2012 page 1 of 10 
Rabies and 
Rabies-Related 
Lyssaviruses 
Hydrophobia, 
 Lyssa 
 
Last Updated: November 2012 
 
 
 
 
Importance 
Rabies is a viral disease that affects the central nervous system (CNS) of 
mammals and has an extremely high case fatality rate. Once clinical signs develop, 
there are very few survivors. Vaccines can protect pets, as well as people exposed to 
these animals, but the maintenance of rabies viruses in wildlife complicates control. 
In humans, illness can be prevented by administering anti-rabies antibodies and a 
series of vaccinations, provided exposure is recognized before the symptoms appear. 
However, people in impoverished countries do not always have access to effective 
post-exposure prophylaxis. Due to this and other factors, such as inadequate levels of 
vaccination in dogs and cats, the annual incidence of human rabies is estimated to be 
40,000 or more cases, worldwide. A few cases occur even in nations with good 
medical care, typically in people who did not realize they were exposed. 
Closely related lyssaviruses circulate among bats in the Eastern Hemisphere, and 
can cause an illness identical to rabies in people and domesticated animals. Rabies 
vaccines and post-exposure prophylaxis are thought to provide some protection against 
some of these viruses, but not others. Rabies-related lyssaviruses can be found even in 
countries classified as rabies-free. 
Etiology 
Rabies is caused by the rabies virus, a neurotropic virus in the genus Lyssavirus, 
family Rhabdoviridae. There are many variants (or strains) of this virus, each 
maintained in a particular reservoir host. The reservoir host may be reflected in the 
case description. For example, if a virus maintained in skunks caused rabies in a dog, 
it would be described as skunk rabies in a dog, rather than canine rabies. 
Closely related lyssaviruses, which are known as rabies-related lyssaviruses or 
nonrabies lyssaviruses, can cause a neurological disease identical to rabies. Lagos bat 
virus, Duvenhage virus, European bat lyssavirus (EBLV) 1, EBLV 2, Australian bat 
lyssavirus (ABLV), Mokola virus and Irkut virus have caused clinical cases in 
humans or domesticated animals, and Ikoma virus was detected in the brain of an 
African civet (Civettictis civetta) with neurological signs. Shimoni bat virus, Aravan 
virus, Khujand virus, Bokeloh virus and West Caucasian bat virus have been found, to 
date, only in bats, but might be pathogenic in other species. Additional rabies-related 
lyssaviruses are likely to exist. 
Rabies virus and the rabies-related lyssaviruses have been classified into two or 
more phylogroups, based on their genetic relatedness. Viruses that are more closely 
related to rabies virus can be neutralized, at least to some extent, by antibodies to 
rabies virus. Phylogroup I contains rabies virus, Duvenhage virus, EBLV 1, EBLV 2, 
Australian bat lyssavirus, Irkut virus, Aravan virus and Khujand virus. Bokeloh virus 
also appears to belong to this group. Phylogroup II consists of Lagos bat virus, 
Mokola virus and probably also Shimoni bat virus. West Caucasian bat virus has been 
provisionally placed in a new group, phylogroup III. Ikoma virus seems to be related 
to West Caucasian bat virus, although a full analysis is not yet available.  
Species Affected 
All mammals are susceptible to rabies, but only a limited number of species also 
act as reservoir hosts. They include members of the families Canidae (dogs, jackals, 
coyotes, wolves, foxes and raccoon dogs), Mustelidae (e.g., skunks), Viverridae (e.g., 
mongooses), and Procyonidae (raccoons), and the order Chiroptera (bats). Although 
cats can be affected by rabies, cat-adapted variants have not been seen. Each rabies 
variant is maintained in a particular host, and usually dies out during serial passage in 
species to which it is not adapted. However, any variant can cause rabies in other 
species. Occasionally, a virus adapted to one species becomes established in another.  
Rabies is maintained in two epidemiological cycles, one urban and one sylvatic. 
In the urban rabies cycle, dogs are the main reservoir host. This cycle predominates in 
areas where the proportion of unvaccinated and semi-owned or stray dogs is high, 
such as some parts of Africa, Asia, the Middle East and Latin America. The urban 
rabies cycle has been virtually eliminated in the U.S., Canada and Europe; although 
sporadic cases occur in dogs infected by wild animals, the urban cycle is not 
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perpetuated in canine populations. However, the canine 
rabies variant is apparently established in some wildlife 
populations (e.g., foxes and skunks in North America) and 
it could be re-established in dogs from these reservoirs.  
The sylvatic (or wildlife) cycle is the predominant 
cycle in Europe and North America. It is also present 
simultaneously with the urban cycle in some parts of the 
world. The epidemiology of this cycle is complex; factors 
affecting it include the virus strain, the behavior of the host 
species, ecology and environmental factors. In any 
ecosystem, often one and occasionally up to 3 wildlife 
species are responsible for perpetuating a particular rabies 
variant. The disease pattern in wildlife can either be 
relatively stable, or occur as a slow moving epidemic. Some 
wildlife maintenance hosts include skunks and bats in the 
Americas, raccoons (Procyon lotor) in North America, 
raccoon dogs (Nyctereutes procyonoides) in Europe and 
Asia, and wolves in northern Europe. Various foxes are 
reservoir hosts in Europe, North America, the Middle East 
and Asia, and mongooses maintain rabies viruses in Asia 
and the Caribbean. Coyotes are reported to be reservoir 
hosts in Latin America, and jackals in the Middle East and 
Asia. Several species including jackals, foxes, mongooses 
and genets might maintain viruses in Africa.  
Rabies-related Lyssaviruses 
With the possible exception of Mokola virus, rabies-
related lyssaviruses seem to be maintained in insectivorous 
bats and fruit bats. They also cause illness in these animals. 
Mokola virus has been detected in shrews and wild rodents, 
but not bats, and its reservoir host is still uncertain. The 
reservoir host for Ikoma virus is also unknown.  
The susceptibility of other mammalian species to 
rabies-related lyssaviruses is incompletely understood. Like 
rabies virus, these viruses might be able to infect all 
mammals. As of 2012, fatal neurological disease has been 
reported in cats, dogs and a water mongoose (Atilax 
paludinosis) infected with Lagos bat virus; cats and dogs 
infected with Mokola virus; cats, sheep and a stone marten 
infected with EBLV 1; and an African civet infected with 
Ikoma virus. Experimental infections with EBLV-1 were 
established in mice, sheep, foxes, ferrets, dogs and cats. It is 
likely that domesticated animals can also be affected by 
other lyssaviruses, such as Duvenhage virus, which has 
caused fatal illness in people. 
Zoonotic potential 
All rabies variants are thought to be zoonotic. Clinical 
cases have also been caused by Duvenhage virus, EBLV 1, 
EBLV 2, Australian bat lyssavirus, Mokola virus and Irkut 
virus. Humans are likely to be susceptible to other rabies-
related lyssaviruses. 
Geographic Distribution 
With some exceptions (particularly islands), rabies 
virus is found worldwide. Some countries such as the 
United Kingdom, Ireland, Sweden, Norway, Iceland, Japan, 
Australia, New Zealand, Singapore, most of Malaysia, 
Papua New Guinea, the Pacific Islands and some 
Indonesian islands have been free of this virus for many 
years. According to the World Health Organization (WHO), 
a country is considered to be free of rabies if there have 
been no indigenously acquired cases in humans or animals 
during the previous 2 years, in the presence of adequate 
surveillance and import regulations. Using this definition, 
several additional countries are considered to be rabies-free. 
In some cases, these nations have conducted rabies 
vaccination programs in wildlife, but are susceptible to the 
reintroduction of the virus from neighboring countries. 
Official lists should be consulted for the current list of 
rabies-free countries and areas, as it may change.  
Rabies related lyssaviruses have been found only in the 
Eastern Hemisphere. There is limited information on the 
distribution of individual viruses within this area. EBLV 1, 
EBLV 2 and Bokeloh virus occur in Europe, Irkut virus and 
West Caucasian bat virus were detected in Russia, and 
Aravan virus and Khujand virus have been found in Asia. 
Antibodies to West Caucasian bat virus were also found in 
Africa, suggesting that it or a related virus might circulate 
there. Viruses that have been reported only from Africa 
include Duvenhage virus, Lagos bat virus, Mokola virus, 
Shimoni bat virus and Ikoma virus. Australian bat 
lyssavirus seems to be limited to Australia, but neutralizing 
antibodies to this or a related virus were found among bats 
in the Philippines. Rabies-related lyssaviruses have not 
been detected in the Americas, where the classical rabies 
virus is common among bats. The presence of a rabies-
related lyssavirus does not prevent a nation from being 
listed as rabies-free. 
Transmission 
Rabies virus has an unusual dissemination pattern in 
the body, which influences its transmission, diagnosis and 
prevention. Immediately after infection, the virus enters an 
eclipse phase during which it replicates in non-nervous 
tissue (e.g., muscle), and is not easily detected. It does not 
usually stimulate an immune response at this time, but it is 
susceptible to neutralization if antibodies are present. After 
several days or months, the virus enters the peripheral 
nerves and is transported to the CNS. After dissemination 
within the CNS, where clinical signs develop as the neurons 
are infected, the virus is distributed to highly innervated 
tissues via the peripheral nerves. The virus is concentrated 
in nervous tissue, salivary glands, saliva and cerebrospinal 
fluid (CSF), which should all be handled with extreme 
caution. Limited amounts of virus have been detected in a 
number of other tissues and organs. Because the virus is 
contained within neurons, handling most body fluids or 
intact organs is thought to be low risk. However, a few 
cases of rabies have been reported in organ transplant 
recipients. Corneas were often involved, but various 
internal organs have also transmitted rabies. Needles or 
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other sharp objects might transmit the virus if they pass 
through tissues, because there is a possibility they may have 
pierced nervous tissue. Feces, blood, urine and other body 
fluids are not thought to contain infectious virus.  
Rabies virus is usually spread between animals in the 
saliva, during a bite from an infected animal. Less often, an 
animal or person is infected by contact with infectious 
saliva or neurological tissues, through mucous membranes 
or breaks in the skin. This virus is not transmitted through 
intact skin. The efficiency of transmission varies with the 
behavior of the infected animal. Animals with the furious 
form are more likely to spread rabies than animals with the 
paralytic form. Carnivores are also more efficient vectors, 
in general, than herbivores.  
Not all rabid animals will transmit the virus to animals 
they bite. Virus shedding is estimated to occur in 50-90% of 
infected animals, and the amount of virus in the saliva varies 
from a trace to high titers. It can be influenced by the species 
of animal and the viral strain. Shedding can begin before the 
onset of clinical signs. Cats have been reported to excrete 
virus for 1-5 days before the signs appear, cattle for 1 to 2 
days, skunks for up to 14 days and bats for 2 weeks. Virus 
shedding in dogs is usually said to be limited to 1-5 days 
before the onset of clinical signs; however, in some 
experimental studies (using viruses of Mexican or Ethiopian 
origin), the virus was present in the saliva for up to 13 days 
before the dogs became ill. In very rare cases, it has been 
suggested that bats or dogs might be able to carry 
lyssaviruses asymptomatically, but this is controversial, and 
has not been unequivocally demonstrated.  
Human saliva contains rabies virus, and transmission 
between people is theoretically possible, but unproven. 
Activities that could pose a risk for exposure include bites, 
kisses or other direct contact between saliva and mucous 
membranes or broken skin, sexual activity, and sharing 
eating or drinking utensils or cigarettes. It is not known how 
long humans can shed the virus before becoming 
symptomatic; the U.S. Centers for Disease Control and 
Prevention (CDC) recommends post-exposure prophylaxis 
for anyone who had at-risk contact with a person during the 
14 days before the onset of clinical signs.  
There are rare reports of transmission by other routes. 
Aerosol transmission has been documented under special 
circumstances, such as in laboratories and a bat cave with 
an unusually high density of aerosolized, viable virus 
particles. Rabies viruses have been transmitted by ingestion 
in experimentally infected animals, and there is anecdotal 
evidence of transmission in milk to a lamb and a human 
infant from their mothers. (More conventional routes could 
not be ruled out in the latter case.) Some authors have 
speculated that ingestion might play a role in rabies 
transmission among wild animals. In one epizootic among 
kudu (Tragelaphus strepsiceros), the virus may have 
spread between animals when they fed on thorn trees. There 
is no evidence that people have ever been infected by eating 
rabies virus (with the possible exception of the case 
described in the infant). 
Rabies-related Lyssaviruses 
There is little information on the transmission of 
rabies-related lyssaviruses, although it is probably similar to 
rabies. Infections with these viruses have been reported 
after bites, scratches or close contact with bats. Bats 
inoculated with Eurasian bat lyssaviruses shed virus in 
saliva shortly before clinical signs developed. In one 
experiment, there was no evidence for transmission to 
uninoculated bats kept in the same cage.  
Disinfection 
Rabies virus can be inactivated by sodium 
hypochlorite, 45-75% ethanol, iodine preparations, 
quaternary ammonium compounds, formaldehyde, phenol, 
ether, trypsin, β-propiolactone, and some other detergents. 
It is also inactivated by a very low pH (below 3) or very 
high pH (greater than 11). This virus is susceptible to 
ultraviolet radiation. It is rapidly inactivated by sunlight and 
drying, and (in dried blood and secretions) it does not 
survive for long periods in the environment. 
Infections in Animals 
Incubation Period 
The incubation period varies with the amount of virus 
transmitted, virus strain, site of inoculation (bites closer to 
the head have a shorter incubation period), pre-existing host 
immunity and nature of the wound. In dogs, cats and 
ferrets, the incubation period is usually less than 6 months; 
most cases in dogs and cats become apparent between 2 
weeks and 3 months. In cattle, the vampire bat variant is 
reported to have an incubation period of 25 days to more 
than 5 months. The incubation period is also usually less 
than 6 months in bats, although some individuals can 
remain asymptomatic for much longer.  
Clinical Signs 
The initial clinical signs are often nonspecific and may 
include fearfulness, restlessness, anorexia or an increased 
appetite, vomiting, diarrhea, a slight fever, dilation of the 
pupils, hyperreactivity to stimuli and excessive salivation. 
The first sign of post-vaccinal rabies is usually lameness in 
the vaccinated leg. Animals often have behavioral and 
temperament changes, and may become either unusually 
aggressive or uncharacteristically affectionate. Pigs 
frequently have a very violent excitation phase at the onset 
of disease. After 2 to 5 days, these signs may be followed 
by a stage during which either the paralytic or the furious 
form of rabies predominates. Survival is extremely rare in 
either form of the illness. 
The paralytic (“dumb”) form of rabies is characterized 
by progressive paralysis. In this form, the throat and 
masseter muscles become paralyzed; the animal may be 
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unable to swallow, and it can salivate profusely. Laryngeal 
paralysis can cause a change in vocalization, including an 
abnormal bellow in cattle or a hoarse howling in dogs. 
There may also be facial paralysis or the lower jaw may 
drop. Ruminants may separate from the herd and can 
become somnolent or depressed. Rumination may stop. 
Ataxia, incoordination and ascending spinal paresis or 
paralysis are also seen. The paralytic form of rabies may be 
preceded by a brief excitatory phase, or none at all. Biting 
is uncommon. Death usually occurs within 2 to 6 days, as 
the result of respiratory failure.  
The furious form of rabies is associated with infection 
of the limbic system, and is the more common form in cats. 
Large animals with this form, such as horses, are extremely 
dangerous due to their size. Furious rabies is characterized 
by restlessness, wandering, howling, polypnea, drooling 
and attacks on other animals, people or inanimate objects. 
Affected animals often swallow foreign objects such as 
sticks and stones. Wild animals frequently lose their fear of 
humans, and may attack humans or animal species they 
would normally avoid (e.g., porcupines). Nocturnal animals 
may be visible during the day. In cattle, unusual alertness 
can also be a sign of this form. Some animals have 
convulsions, especially during the terminal stages, and 
death sometimes occurs during a seizure. In most cases, 
however, the illness eventually progresses to incoordination 
and ascending paralysis. Animals with furious rabies 
usually die 4 to 8 days after the onset of clinical signs.  
The signs of rabies can be highly variable, and many 
cases do not fit neatly into either the classic furious or 
paralytic presentation. The most reliable diagnostic signs 
are behavioral changes and unexplained paralysis, but 
rabies should be a consideration in all cases of unexplained 
neurological disease. For example, there have been cases in 
cats where no behavioral changes were noticed, and the 
illness appeared only as ataxia or posterior weakness, 
followed by ascending paralysis. Horses and mules are 
often in distress and extremely agitated, which may be 
interpreted as colic. Diagnosis can be particularly difficult 
in rabbits and rodents unless there is a history of exposure 
to a potentially rabid animal, such as a raccoon. Some 
infected rabbits developed obvious neurological signs, often 
of the paralytic form, but others had signs that were not 
initially suggestive of rabies, or experienced only 
nonspecific illness before death. In one report, sudden death 
was the only sign in many infected squirrels.  
Rabies-related Lyssaviruses 
Information about rabies-related lyssaviruses is 
currently limited to a handful of case reports and a few 
reports of experimental inoculation. In the case reports, 
these viruses caused fatal neurological disease in various 
wild and domesticated animals. Various inoculation routes, 
including intracerebral, intravenous and intramuscular 
injection, were used in several species of experimentally 
infected animals. Some animals developed severe 
neurological signs and died, while others were 
asymptomatic or had milder clinical signs and survived. 
Some mild cases might have resulted from using less 
virulent viruses (e.g., less pathogenic strains, or attenuated 
viruses propagated in the laboratory). For example, early 
studies suggested that phylogroup II viruses were less 
virulent than phylogroup I viruses; however, this is no 
longer thought to be true. Pre-existing immunity might also 
have contributed to survival in wild-caught bats.  
The occurrence of healthy carriers among bats is 
controversial. There is one report that apparently healthy 
bats shed EBLV-1. 
Post Mortem Lesions 
There are no characteristic gross lesions. The stomach 
may contain unusual objects that were ingested. The typical 
histological signs, found in the CNS, are multifocal, mild, 
polioencephalomyelitis and craniospinal ganglionitis with  
mononuclear perivascular infiltrates, diffuse glial 
proliferation, regressive changes in neuronal cells, and glial 
nodules. Aggregates of viral material in neurons (Negri 
bodies) can be seen in some but not all cases.  
Diagnostic Tests 
In animals, rabies virus is usually identified by 
detecting viral antigens in a brain sample taken at necropsy. 
The virus might also be found in other tissues such as the 
salivary gland, skin (tactile facial hair follicles) and corneal 
impression smears, but detection is less efficient. 
Immunofluorescence is the most commonly used assay, and 
is most effective on fresh samples. It can identify 98-100% 
of cases caused by all genotypes of the rabies and rabies-
related lyssaviruses, using brain tissues. The usual 
immunofluorescence assay cannot, however, distinguish 
these viruses. Immunohistochemistry and enzyme-linked 
immunosorbent assays (ELISAs) can also be used to detect 
antigens. RT-PCR can be useful, particularly when the 
sample is small (e.g., saliva) or when large numbers of 
samples must be tested in an outbreak or epidemiological 
survey. Histology to detect Negri bodies is nonspecific, and 
it is not recommended if more specific techniques are 
available.  
A single negative test does not rule out infection; 
therefore, virus isolation in cell culture (e.g., mouse 
neuroblastoma cells) is often done concurrently. Mouse 
inoculation may also be used in some circumstances, but cell 
culture is preferred. Identification of rabies virus variants or 
other species of lyssaviruses is done in specialized 
laboratories using monoclonal antibodies, specific nucleic 
acid probes, or RT-PCR followed by DNA sequencing. 
Serology is occasionally used to test seroconversion in 
domesticated animals before international travel, as well as 
during wildlife vaccination campaigns or in research. It is 
rarely useful for diagnosing clinical cases, as the host 
usually dies before developing antibodies. Serological tests 
include virus neutralization tests and ELISAs. Rabies virus 
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and rabies-related lyssaviruses cross-react, but the assays do 
not detect antibodies to most other rhabdoviruses. Some 
cross-reactive epitopes have been reported in members of 
the Ephemerovirus genus (bovine ephemeral fever virus 
and closely related viruses).  
Treatment 
There is no treatment once the clinical signs appear. 
Post-exposure prophylaxis of animals, as described below 
for humans, is usually considered inadvisable because it 
may increase human exposure. Post-exposure prophylactic 
procedures for animals have not been validated and are 
either prohibited or not recommended in the U.S. and many 
European countries. This is not the case in all parts of the 
world, and commercial vaccines are licensed for this 
purpose in some countries.  
Control 
Disease reporting  
A quick response is important for minimizing exposure 
to a rabies case, even in endemic regions. Veterinarians 
who encounter or suspect rabies should follow their 
national and/or local guidelines for disease reporting. In the 
U.S., state authorities must be notified immediately. 
Prevention  
In animals, rabies prevention is based on vaccination and 
the avoidance of contact with infected animals (e.g., 
preventing pets from roaming, housing pet rabbits and rodents 
indoors). Rabbits kept outside should be in an elevated, 
double-walled hutch that does not have exposed wire mesh 
floors. Bats caught by cats should be submitted for rabies 
testing. Six-month quarantines have been recommended for 
all wild-caught mammals added to collections. This is 
expected to identify most infected animals, though rare cases 
may become apparent after this time. 
Vaccination is recommended for dogs, cats and ferrets, 
to reduce human exposure as well as to protect the animal. 
Both inactivated and modified live vaccines are effective in 
dogs and cats, but rare cases of post-vaccinal rabies have 
been reported with modified live vaccines. Rabies vaccines 
are also available for livestock. Vaccines have not been 
validated in rabbits or rodents, although they might be used 
extralabel in petting zoos or other facilities where animals 
are in contact with the public. Vaccination programs in 
wildlife, using oral vaccines, protect domesticated animals 
as well as people. In countries with large stray dog 
populations, similar oral vaccines may be useful.  
Rabies vaccines are all based on rabies virus, and seem 
to provide little or no protection from rabies-related 
lyssaviruses in phylogroup II or those provisionally 
classified in phylogroup III. Limited vaccination and 
challenge studies suggest that they may provide some cross-
protection against rabies-related lyssaviruses in phylogroup 
I. Within phylogroup I, the amount of protection may vary 
with the specific virus.  
The specific regulations for domesticated animals 
exposed to a rabid animal vary with the country, species of 
animal and vaccination status. If an unvaccinated animal is 
exposed to rabies virus in the U.S., authorities recommend 
that it be euthanized and tested. This prevents unnecessary 
prophylaxis in people who may have been exposed, and 
also reduces the risk that it will infect other people or 
animals. If the owner is unwilling to allow euthanasia, the 
animal may be placed in strict isolation for 6 months. If a 
vaccinated animal is exposed to rabies in the U.S., it is 
revaccinated and confined under observation for 45 days. 
Animals with expired vaccinations are evaluated on a case-
by-case basis. 
Most countries have regulations to prevent the 
importation of rabies in animals. These regulations vary 
with the country and animal species, and may include 
quarantine or testing for vaccine-induced seroconversion.  
Morbidity and Mortality 
The incidence of rabies in domesticated animals varies 
with the region. Canine rabies was once very common 
worldwide, but it has been controlled, or even eradicated, in 
some countries. In some countries (e.g., the U.S.), cats are 
now more likely to develop rabies than dogs, probably due 
to the lower vaccination rates in this species, combined with 
greater exposure to wildlife. Rabies is reported infrequently 
in ferrets, and rarely documented in rabbits and rodents. 
Sylvatic and urban rabies cycles occur concurrently in some 
regions, while the sylvatic cycle predominates in others. For 
example, wild animals accounted for more than 90% of the 
animal rabies cases reported in the U.S. and Canada in 
2010. Rabies can be a serious concern in some rare or 
endangered species. In Africa, the Ethiopian wolf (Canis 
simensis) and African wild dogs (Lycaon pictus) are 
threatened by this virus. Although cases of rabies tend to 
be sporadic, epizootics are possible. Outbreaks occur 
among cattle bitten by vampire bats (Desmodus rotundus) 
in South America. Epizootics have also been reported 
occasionally among wildlife, such as kudu in Africa.  
All animals exposed to rabies virus do not become ill. 
Factors that may affect the outcome of exposure include 
the virus variant, presence in saliva at the time of the bite, 
dose of virus, route and location of exposure, and host 
factors such as the species of animal, age and existing 
immunity to lyssaviruses. Experiments in bats and dogs 
suggest that some animals can survive and become 
resistant to reinfection. Antibodies have also been found 
in a few cats with no history of vaccination. Reports of 
animals surviving after the development of clinical signs 
are very rare, but do exist. In one well-documented case, 
an experimentally infected ferret (skunk origin virus) 
developed neurological signs and had evidence of 
infection in the CSF, but recovered with persistent 
hindlimb paralysis. There was no evidence of any residual 
virus at the time of euthanasia.  
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Rabies-related Lyssaviruses 
Although some rabies-related lyssaviruses are common 
in bats, only a few clinical cases have been reported in 
domesticated animals. All of these cases were fatal. 
Infections in Humans 
Incubation Period 
In humans, the incubation period can be a few days to 
several years. Most cases become apparent after 1-3 months. 
Clinical Signs 
Nonspecific prodromal signs may be seen during the 
early stage of rabies. They can include malaise, fever or 
headache, as well as discomfort, pain, pruritus or other 
sensory alterations at the site of virus entry. After several 
days, anxiety, confusion and agitation may appear, and 
progress to insomnia, abnormal behavior, hypersensitivity to 
light and sound, delirium, hallucinations, slight or partial 
paralysis, hypersalivation, difficulty swallowing, pharyngeal 
spasms upon exposure to liquids, convulsions and other 
neurological signs. Either an encephalitic (furious) form with 
hyperexcitability, autonomic dysfunction and hydrophobia, 
or a paralytic (dumb) form characterized by generalized 
paralysis, may predominate. Death usually occurs within 2 to 
10 days.  
Survival is extremely rare in clinical cases, and 
survivors are often left with severe neurological deficits. 
However, there are a few documented cases where patients 
with relatively mild neurological signs recovered well. 
Rabies-related Lyssaviruses 
Only a few infections with rabies-related lyssaviruses 
have been reported. These patients developed neurological 
signs, similar to rabies, and nearly all cases were fatal. 
Diagnostic Tests 
Antemortem diagnosis is sometimes possible in people 
with rabies symptoms. RT-PCR or immunofluorescence may 
detect viral nucleic acids or antigens in saliva, or in skin 
biopsies taken from the nape of the neck. In skin, the virus 
occurs in the cutaneous nerves at the base of the hair follicles. 
Rabies virus is sometimes found in corneal impressions or 
eye wash fluid, and RT-PCR may occasionally detect nucleic 
acids in CSF or urine. Virus isolation is sometimes possible 
from the saliva, conjunctival secretions/tears, corneal 
impressions, skin biopsies or (less often) CSF in living 
patients. More than one test is usually necessary for an 
antemortem diagnosis, as the virus is not invariably present 
in any tissue other than the CNS. Detecting antibodies to 
rabies virus in CSF is definitive, and indicates that the virus 
is replicating in the CNS. Neutralizing antibodies do not 
usually appear in the blood until late, and infected people 
may still be seronegative when they die. Rabies is usually 
undetectable during the incubation period. After death, 
rabies virus can be detected in the brain, as in animals.  
Rabies-related Lyssaviruses 
Infections with rabies-related lyssaviruses are easily 
misdiagnosed as rabies. The immunofluorescence test used 
for postmortem rabies diagnosis can detect these viruses, 
but does not recognize them as different from rabies virus. 
The specific virus can, however, be identified with tests 
based on monoclonal antibodies, or by PCR.  
Treatment 
Post-exposure prophylaxis consists of immediate wound 
cleansing, followed by the administration of human rabies 
immunoglobulin and several doses of human rabies vaccine. 
Fewer vaccine doses and no rabies immunoglobulin are 
given if the person was previously vaccinated. In 
unvaccinated patients, the recommended number of vaccine 
doses can vary with the availability of high quality 
biologicals, the performance of initial wound care, and 
whether the patient is immunocompetent or immuno-
suppressed. Post-exposure prophylaxis is highly effective if it 
is begun soon after exposure. 
There is no single, recommended treatment once rabies 
symptoms develop. The ideal treatment is unknown, and both 
aggressive treatment and supportive therapy have a very high 
risk of failure. A number of experimental therapies (e.g., 
vaccines, antiviral agents, antibodies to rabies virus, 
ketamine and/or the induction of a therapeutic coma) have 
been tried in the past, but were usually ineffective. Some 
treatments, such as therapeutic coma, are controversial. One 
young patient who recovered well was treated with ribavirin, 
amantadine and supportive care including therapeutic coma 
(the “Milwaukee protocol”); however, the same treatment 
protocol has been unsuccessful in a number of other patients. 
Two young patients recently recovered with only supportive 
therapy. Currently, the CDC does not advocate either 
supportive therapy or aggressive treatment, and instead states 
that either may be offered. If treatment is successful in 
sustaining life, the patient may be left with permanent, and 
possibly severe, neurological deficits.  
Control 
Controlling rabies in domesticated and wild animals, 
mainly through vaccination, reduces the risk of exposure in 
humans. Wild animals should not be handled or fed; 
wildlife behaving abnormally should especially be avoided. 
Bats should be kept out of houses and public buildings. 
Although pasteurized milk and cooked meat are not 
expected to contain infectious rabies virus, which is 
inactivated by heat, ingesting any product from a rabid 
animal is not recommended. 
Veterinarians and animal control officers should handle 
potentially rabid animals with extreme caution. In addition 
to the risk of contracting rabies, these animals can be very 
unpredictable and can attack without warning. Protective 
clothing such as thick rubber gloves, eye goggles and a 
plastic or rubber apron should be worn when doing 
autopsies, or in other circumstances when exposure to 
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infectious tissues could occur. Sick animals, including 
rabbits and rodents, should not be sent home if they have 
been exposed to potentially rabid wildlife, even if the 
clinical signs do not immediately suggest rabies. 
Bites, needlestick injuries, and other exposures should 
be reported immediately so that they may be evaluated, and 
any necessary post-exposure prophylaxis can begin 
promptly. Non-bite exposures, defined as the contamination 
of mucous membranes or broken skin with saliva, nervous 
tissue, or other potentially infectious material, are evaluated 
for prophylaxis on a case-by-case basis.  
To protect people from animals that may be in the early 
stage of rabies, asymptomatic dogs, cats or ferrets that have 
bitten humans are confined under observation for a short 
period (e.g., for 10 days in the U.S.). If the animal develops 
signs of rabies during this time, it is euthanized and tested. 
It is not known whether the rabies status of lagomorphs and 
rodents can be determined by observation during a 10-day 
confinement. Until research establishes the viral shedding 
period in these species, human bites and scratches are 
evaluated individually for post-exposure prophylaxis. 
Factors that are considered include the animal’s species, the 
circumstances of the bite and the epidemiology of rabies in 
the area, as well as the biting animal’s history, current 
health status and potential for exposure to rabies. Similar 
considerations also apply when the companion animal 
belongs to other species in which the disease is 
incompletely understood. 
Inactivated human vaccines are available for at risk 
veterinary staff, other animal handlers, wildlife officers, 
laboratory workers and others at high risk of exposure. 
International travelers may be vaccinated, depending on 
their destination and other risk factors. People in high risk 
occupations should have their antibody titers monitored 
periodically, with revaccination as needed. The 
recommended monitoring interval varies with the type and 
frequency of exposure. Vaccination does not eliminate the 
need for post-exposure prophylaxis, but fewer treatments 
are needed. It may also provide some protection if the 
person is unaware of the exposure or post-exposure 
prophylaxis is delayed.  
Rabies-related Lyssaviruses 
All currently licensed vaccines are based on rabies 
virus, and do not contain antigens from other lyssaviruses. 
Nevertheless, limited, preliminary studies in animals 
suggest that these vaccines may provide some protection 
against other phylogroup I viruses. In Europe, vaccination 
is recommended for people who regularly handle bats and 
may be exposed to lyssaviruses. Precautions should also be 
taken to avoid bites and scratches. If an injury occurs, the 
wound should be cleansed and brought to the attention of a 
physician. Some sources recommend rabies booster 
vaccination/ post-exposure prophylaxis if the bat is not 
available for testing. 
Morbidity and Mortality 
The risk of developing rabies varies with factors such 
as a person’s occupation, recreational activities and 
geographic location. Rabies is a very common disease in 
some parts of the developing world. Worldwide, 10 million 
people are estimated to receive post-exposure prophylaxis 
each year, and 40,000 or more to die of this illness. Most of 
these cases occur in Africa and Asia, and over 90% are 
caused by rabid dogs. In contrast, human rabies is rare in 
countries where canine rabies has been controlled or 
eliminated, and effective post-exposure prophylaxis (with 
high quality reagents) is available. In the U.S., only 0-3 
cases of rabies are usually reported in people, each year. In 
developed countries, rabies typically occurs in people who 
did not realize they were exposed, or for some other reason, 
did not seek medical treatment. 
Without post-exposure prophylaxis, an estimated 20% 
of humans bitten by rabid dogs develop rabies. Once the 
symptoms appear, rabies is almost always fatal, regardless 
of treatment. There are currently less than a dozen well-
documented cases of survival, and only a few of these 
patients made a good recovery. Until recently, all rabies 
survivors were people who received vaccine before the 
onset of symptoms (it is also possible that some of these 
patients had post-vaccinal encephalomyelitis rather than 
rabies). Most were left with severe neurological 
complications. Since 2004, there have been at least 3 
reports of young patients who survived with few or no 
residual neurological signs. All three had neutralizing 
antibodies to rabies virus at diagnosis, although none had 
been vaccinated. They also had relatively mild neurological 
signs when they were seen by a physician. One patient was 
treated aggressively with antiviral drugs and the induction 
of a therapeutic coma, but the other two received only 
supportive therapy. One of these patients appeared to have 
been infected 2 years earlier. The reasons for their good 
outcomes are uncertain, but potential factors include the 
patients’ young age and good health, the mild neurological 
signs at presentation, or the type/origin of the virus (e.g., a 
less virulent strain). Based on limited serological evidence, 
especially in one South American population, it appears 
that subclinical infections might also be possible in humans. 
However, this remains to be proven. 
Rabies-related Lyssaviruses 
Infections with rabies-related lyssaviruses seem to be 
rare, but might be underdiagnosed, as they can easily be 
mistaken for rabies. Some of these viruses also occur in 
areas where diagnostic capabilities and surveillance are 
limited. Almost all symptomatic cases have been fatal. One 
child thought to have been infected with Mokola virus 
recovered; however, there is some question whether this 
child was actually infected with the virus. Recently, another 
child did not become ill after receiving a bite from an 
Ikoma virus-infected civet with neurological signs. The 
child received wound care and post-exposure rabies 
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vaccination, but its efficacy against this virus is not known. 
It is uncertain whether the civet was shedding virus at the 
time of the bite.  
Internet Resources 
Centers for Disease Control and Prevention (CDC)  
http://www.cdc.gov/rabies/ 
Compendium of Animal Rabies Prevention and Control, 
2011 
http://www.cdc.gov/mmwr/pdf/rr/rr6006.pdf 
International Veterinary Information Service (IVIS)  
http://www.ivis.org 
Public Health Agency of Canada. Pathogen Safety  
Data Sheets 
http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/index-
eng.php 
The Merck Manual 
http://www.merck.com/pubs/mmanual/ 
The Merck Veterinary Manual 
http://www.merckvetmanual.com/mvm/index.html 
World Health Organization 
http://www.who.int/mediacentre/factsheets/fs099/en/ 
World Organization for Animal Health (OIE) 
http://www.oie.int/ 
OIE Manual of Diagnostic Tests and Vaccines for  
Terrestrial Animals 
http://www.oie.int/international-standard-
setting/terrestrial-manual/access-online/ 
OIE Terrestrial Animal Health Code 
http://www.oie.int/international-standard-
setting/terrestrial-code/access-online/ 
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